Hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV) are 16 transfusion transmissible infections (TTIs) agents that threaten the safety of the blood 17 supply. Surveillance of the variance of those viruses is an important way to monitor their 18 diversity and evolution to improve safety in blood transfusion. In this study, we 19 characterized the specimens of blood donors from 13 blood centers located in 5 Chinese 20 regions. 21 determine whether the distributions of variants are changing over time and 47 geographically, and to speculate whether previously rare subtypes are becoming 48 established in blood donors in China. 49
Samples collected between 2014 and 2017 were screened with serological and 22 molecular tests conducted on Abbott ARCHITECT and m2000 platforms. Sequencing 23 was used to determine the classifications. The HBV immune escape mutations were 24 also analyzed for assessing vaccine breakthrough risks and challenges for diagnostic 25 tests. For HIV, 11 genotypes or recombinants were identified. The predominant 26 genotype was C, which accounts for 42%. For HBV, the genotypes of B, C and D were 27 identified, with B and C predominating. The major subgenotype was B2, comprising 84.1% 28 of all infections. 79 out of 113 (69.9%) samples carried escape mutations in the "a" 29 determinant region with 69 (87.3%) multiple mutants and 15 (19%) escape mutants 30 which will affect HBsAg detection. For HCV, 7 genotypes or subtypes were identified. 31
The major genotype was 1b (48%), followed by 6a (16.7%) and 2a & 3a (10%). This 32 study provides the information of diversity of HBV, HCV and HIV strains circulating in 33 blood centers from 5 regions in China. These data can also be scientific basis for 34 development of detection assays that mitigate the impact of viral diversity on 35 performance. 36
Importance: 37
The prevalence of TTIs in blood donations is important for evaluating blood safety and it 38 can also reflect the burden of these disease among populations. Virus variance is threat 39 to blood safety due to it may affect assays detection by nucleic acid, antigen and 40 antibody-based methods in blood donors. HIV, HBV and HCV exhibit high degrees of 41 genetic diversity, with different strains predominating in different geographic locations. 42
The aim of this study is to assess the diversity of HBV, HCV and HIV among blood 43 donors in China. In this study, 13 blood centers located in 5 Chinese regions were 44 involved and the most informative phylogenetic regions of each virus had been 45 sequenced. This will benefit for viral monitoring by subtype/genotype analyses to 46 Introduction 50 Hepatitis B (HBV), hepatitis C (HCV) and human immunodeficiency virus (HIV) are three 51 important transfusion-transmitted infectious agents which are threats to blood safety in 52
China (1). Before 1998, a high number of HBV, HCV, and HIV infections in China were 53 from a blood transfusion. Since the three agents were included for blood screening, 54 especially nucleic acid testing of the three agents conducted for all blood donors, the 55 infection of the three agents through blood transfusion decreased significantly. However, 56 the threat of these agents to blood safety still exists in China (2). 57
Several studies have reported the molecular epidemiological data of the three agents in 58 general populations in China. The first nationwide molecular epidemiological survey of 59 HIV conducted in 1996-1998 showed that subtype B'/B (47.5%), subtype C (34.3%), and 60 CRF01_AE (9.6%) were the most predominant strains in China (3). However, the 61 second and third surveys conducted in 2002-2003 and 2006 indicated that the 62 proportions of HIV-1 genotypes had sharply shifted. The subtype B'/B and C have been 63 replaced by CRF07_BC, CRF01_AE, and CRF08_BC (4, 5) . 64 HBV and HCV genotypes have geographic distribution characteristics (6-8). HBV has 9 65 genotypes (A-I) (9) and more than 35 subgenotypes that have been identified (10). 66
Genotypes B and C are the predominant HBV strains in China. North of the Qinling 67
Mountains-Huaihe River Line, genotype C (75.3%) is dominating with a small portion of 68 types B (23.4%) and D (1.3%) (11). In the south of China, the major genotype is B (12). 69
The distribution of HCV genotypes is closely related to the modes of HCV acquisition 70 (13). In the late 1980s and early 1990s in China, illegal blood collection and donation 71 greatly promoted the spread of HCV genotype 1 and 2 (14). In 1998, mandatory HCV 72 screening of blood and blood products was implemented in China, gradually changing 73 the predominant mode of HCV transmission from direct contact with human blood to 74 intravenous and percutaneous drugs used (15). Consequently, the HCV genotype 75 distribution in China has been shifting over time, especially in the southwestern 76 provinces (16). In China, the only multicenter investigation of the distribution of HCV 77 genotypes, conducted in 2011, indicated that the most prevalent HCV subtype was 1b, 78 followed by 2a (17). Over time, the prevalence of genotypes 3, 6, and new mixed-79 infection genotype has also been increasing (18) . 80
These data indicate the diversity of HIV, HBV, and HCV and the importance of 81 monitoring virus diversity and evolution for blood safety in China. Except for the diversity 82 of genotypes, mutations in the sequences of these agents may lead to false-negative 83 detection in blood screening and introduce TTIs that jeopardizes the blood safety. Take 84 the mutants of HBV as an example, the mutants in "a" determinant region which located 85 in the major immunogenic region can lead to false-negative detection, vaccine escape 86 and may evade natural immune responses (19) . In previous reports, the sG145R mutant 87 is the most widely reported. Besides sG145R, the K141E, T131I, and insertion of amino 88 acids between 123 and 124 can affect the structure of HBsAg to cause vaccine escape 89 as well (20) . Recently, other mutants in "a"-determinant region are linked to vaccine 90 escape, like T116N, P120S/E, I/T126A/N/I/T126A/N/I/S, Q129H/R, M133L, K141E, 91
P142S, and D144A/E (21) 92
Considering the importance of the molecular epidemiological characteristics of these 93 agents in blood donors for blood safety, we performed molecular surveillance of HIV, 94 HBV, and HCV to determine the genotype diversity and characteristics of HBV S region 95 amongst blood donors in 5 Chinese regions. 96
Methods 97
Samples 98
Retrospective leftover plasma from 216 HIV, 207 HBV, or 204 HCV available positive 99 blood donations collected from 13 blood centers in four provinces and one municipality 100 (Chongqing, Guangxi, Henan, Sichuan, Xinjiang) between 2014 and 2017 were included 101 in the study. All positive donations were screened with two ELISA assays as previously 102 described at the blood centers where they were first collected (22). These samples were 103 
HCV phylogenetic classification 163
Sequence data were edited and assembled using Sequencher version 5.4.6 (Gene 164
Codes Corp, Ann Arbor, MI, USA). Sequences were aligned to N=117 reference strains, 165
including subgenotypes of HCV genotypes 1-7 by MUSCLE in Sequencher. Gaps were 166 manually removed in BioEdit version 7.0.4.1(25), and Neighbor-Joining phylogenetic 167 inference was performed using the PHYLIP 3.5c (J. Felsenstein, University of 168 Washington, Seattle, WA, USA) software package as previously described (23). 169
HBV phylogenetic classification and mutation analysis 170
Sequence data was analyzed using Sequencher version 5.2.3 or higher (Gene Codes 171
Corp., Ann Arbor, MI). To determine the genotype of HBV, the DNA sequences were 172 aligned with genotype reference sequences using the CLUSTALW method and manually 173 edited in BioEdit 7.0.4.1 or higher (24). Phylogenetic trees were prepared as described 174
above for HIV and visualized in FigTree v1.4.2 (University of Edinburgh, UK). HBsAg 175 subtype was determined as described in a previous paper (25). HBsAg escape 176 mutations were identified using the web-based program Geno2pheno (hbv) v2.0 177 (Informatik). 178 HIV, N=113 HBV, and N=60 HCV specimens (Table 1 ). The collection sites and 194 demographics of the donors of these sequenced specimens were summarized in Figure  195 1. The majority of donors were male (N=200, 71.4%), Han (N=257, 91.8%), and from 196
Chongqing (N=179, 63.9%). Donor ages ranged from 18 to 59 years old, and the 197 average age was 35 Junior, Bachelor and High school students account for 235 (84%). 198
Technical secondary school, Primary school, Master and Bachelor Junior account for 26 199 (9%), Other 19 (6.79%) donors were unknown education status. The most represented 200 occupation was freelancers 72 (25.71%), followed by students 42 (15%), Agriculture, 201 was higher than or equivalent to a high school degree. 71 (33%) individuals were Junior 214 degree. Similar results were described in a previous report (27) . The freelancers (53, 215 25%) were major infected populations, followed by commercial service personnel (28, 216 13%), then farmer (14, 7%), and others (45, 20%) with the unknown occupation. 217
Two fragments, env IDR and pol INT, were taken into account for analysis except for the 218 samples, which failed to obtain both of those two regions, to determine genotypes of 107 219 sequenced samples. Two genotypes B and C were identified with four types of CRFs 220 (CRF 01, CRF07, CRF08, CRF55) and 5 URFs (URF_0107, URF_01C, URF_0708, 221 URF_BU and URF_CU). The majority of samples genotype were C (42%), followed by 222 CRF01_AE (24%) and CRF07 (17%) ( Amongst 107 classified samples, 75% was from Chongqing and Sichuan, which is 230 located in the Southwest of China (Table 3 ). The C was the majority genotype in 231
Chongqing, Sichuan, and Xinjiang s. Genotype C, CRF01, CRF07 and CRF55 were 232 almost equally distributed in Henan province. In Guang Xi province, the major genotype 233 was CRF01, which was concordant with a previous study (28) . sequenced with at least one sequence. The HBV genotype/subgenotype was analyzed. 247
The three genotypes B, C and D were identified (Table 4 ). Genotype B and C were 248 predominant. Genotype B was the most common genotype (89.4%), and B2 was a major 249 subgenotype (84.1%). 9.8% genotype C and 0.9% genotype D were identified. This was 250 in line with a previous publication (29), but in our study, the proportion of genotype B 251 was higher, which may be due to almost all samples analyzed being from a single 252
Chongqing blood center located in the southwest of China. 253 19 (24.1%) had escape mutants (Figure 2) , which can escape antibody detection and 263 neutralization. The mutation rate was much higher than previous report 17. 1% (29) in 264 blood donors in China, also higher than reported elsewhere, including Japan (24%) (30), 265
Korea (50%) (31), France (28%) (32) and Spain (40%) (33). In this study, there was no 266 mutant identified in position 145, which was the most widely reported. The most frequent 267 mutations found (Figure 2 ) in the study were located in position 133, then 129 and 134, 268 which was different from a previous report (34) . Total escape mutations in "a" determinant residues sequence in the 5'UTR-Core region. 66.7% of donors were male and 33.3% were female. 273
The mean age of donors was 36.2±10.6. The majority of ethnicity was Han (48, 80.0%) 274 and with minorities Zhuang (6, 10%), Miao (1, 1.7%), Mulao (1, 1.7%), Qiang (1, 1.7%), 275
Tujia (1, 1.7%) and Uyghur (2, 3.3%) (Table1, D). In total, 7 genotypes and 276 subgenotypes were identified, namely, 6, 6a, 1a, 1b, 2a, 3a, 3b. The predominant 277 genotype was 1b (N=29, 48%), followed by 6a (N=10, 17%), 2a (N=6, 10%), 3a (N=6, 278 10%) and small proportion of 3b, 6 and 1a ( Table 5 ). The distribution of HCV 279 classifications was concordant with a previous national wide investigation of HCV in 280 mainland China, which reported the major HCV genotypes were 1b and 2a, accounting 281 for 54.5% and 16. 7%, respectively (35) . In our study, 6a was a second major genotype. 282
It was the dominant genotype in Liuzhou blood bank located in the south of China, which 283 was similar to the publication of HCV subtypes of blood donors from 17 provinces and 284 municipalities (36). 285 found to be dominant in the transmitted sexual population in China (37), while 295 CRF_07BC and CRF_08BC were mainly prevalent in IDU population (38). In addition, 296 CRF07_BC was the most predominant strain in the north-western region, which 297 suggested a lack of incoming transmissions from other regions (4). Although CRF01_AE 298 only accounts for 5% of HIV cases worldwide, it plays an important role in China (39). In 299 our study, the finding is in line with the previous study with the fact that the major CRFs 300 are BC recombinant and the predominant CRF in the south of China is CRF01_AE. The 301 limitation of the analysis is that most of the samples have one region (Pol or Env) 302 involved in the analysis, which doesn't have a breakpoint to judge whether it's 303 CRF07_BC or not. That's why C is the majority genotype in our study. If we had 304 complete genomes for classification, the CRF07_BC's proportion should be higher. 305
Surveillance of HBV variants can help in monitoring the diversity and evolution of HBV. 306
The investigation of HBV genotypes and mutations in blood donors will provide evidence 307 to improve current sensitivity and specificity of screening assays and reduce TTIs in 308 blood transfusion. According to the previous study (29), genotype B and C were the 309 major genotypes in Chinese blood donors that is consistent with our study. However, 310 other studies reported that genotype C has a higher prevalence in patients than 311 genotype B (34, 40, 41) , which is different from in blood donors. The most-reported 312 mutant in "a" determinant is G145R which will affect HBsAg detection (21, 42) . In our 313 study, there is 69.9% of the HBV samples were found mutants in "a" determinant region 314 with a distribution of escape mutants in "a" determinant region 69 (87.3%) multiple 315 mutants and 19 (24.1%) escape mutants which will affect HBsAg detection. It indicates 316 possible false-negative results of blood screening of HBsAg and further increase the 317 potential threat of HBV to blood safety in China, which needs to be clarified by further 318
studies. 319
Long-term multi-center molecular surveillance of HIV, HBV, and HCV amongst blood 320 donors provides a detailed picture of the diversity distribution and variations, including 321 new mutations and new subgenotypes occurrence in blood donors. It is very crucial to 322 provide an efficient way to reduce transfusion-transmitted infections of HIV, HBV, and 323 HCV and to improve blood safety further. 324 325
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